Product Information
FETZIMA ER 120 MG CAPSULE is a brand product labeled by Allergan, Inc., priced at $17.5869 per EA under NDC 00456221230. Its NADAC has been published 623 times since Jul 23, 2014.
Strength
120 mg/1
Manufacturer
Allergan, Inc.NDC
00456221230
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LEVOMILNACIPRAN HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA204168On Market Since
7/25/2013
Pharmacological Classes
Price Statistics
The NADAC for FETZIMA ER 120 MG CAPSULE has been published 623 times since Jul 23, 2014, and over the history we have for it it has risen 169.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $17.5869 per EA |
|---|---|
| All-time high | $17.5869 (Jun 24, 2026) |
| All-time low | $6.4977 (Aug 20, 2014) |
| 52-week high | $17.5869 |
| 52-week low | $16.7494 |
| Median price | $13.1920 |
| Average price | $12.8361 |
| Largest weekly change | +16.9% (Oct 8, 2014) |
| Weeks tracked | 623 |
| Tracking since | Jul 23, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the LEVOMILNACIPRAN HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of FETZIMA ER 120 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FETZIMA ER 120 MG CAPSULE, manufactured by Allergan, Inc., is $17.5869 per EA (NDC 00456221230), effective Jun 24, 2026.
How has the price of FETZIMA ER 120 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FETZIMA ER 120 MG CAPSULE has risen 169.7%. It has been tracked across 623 weekly CMS publications since Jul 23, 2014.
What are the highest and lowest recorded NADAC prices for FETZIMA ER 120 MG CAPSULE?
Since Jul 23, 2014, the NADAC for FETZIMA ER 120 MG CAPSULE has ranged from a low of $6.4977 (Aug 20, 2014) to a high of $17.5869 (Jun 24, 2026), with a median of $13.1920 per EA.
Are there cheaper alternatives to FETZIMA ER 120 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of FETZIMA ER 120 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures FETZIMA ER 120 MG CAPSULE?
FETZIMA ER 120 MG CAPSULE (NDC 00456221230) is labeled by Allergan, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification